$364 Million is the total value of Ghost Tree Capital, LLC's 52 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FREQ | Exit | FREQUENCY THERAPEUTICS INCput | $0 | – | -100,000 | -100.0% | -0.22% | – |
| APVO | Exit | APTEVO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.36% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWput | $0 | – | -100,000 | -100.0% | -0.48% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -200,000 | -100.0% | -0.49% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.53% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -17,500 | -100.0% | -0.75% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -250,000 | -100.0% | -0.94% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -125,000 | -100.0% | -1.02% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -500,000 | -100.0% | -1.17% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -1.20% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -275,000 | -100.0% | -1.51% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -30,000 | -100.0% | -1.56% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -225,000 | -100.0% | -2.27% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -200,000 | -100.0% | -4.17% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -150,000 | -100.0% | -11.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.